Dr. Frères balances the management of clinical oncology units with sophisticated research into molecular biomarkers for treatment response.

Academic Titles & Degrees:  MD and PhD (University of Liège).

Current Executive & Clinical Appointments:  Head of the Clinical Oncology Unit at CHU de Liège; Associate Professor at the University of Liège Faculty of Medicine.

Research Axes & Leadership:  Research into circulating microRNAs (miR-34a and miR-122) as predictive markers for chemotherapy response; management of febrile neutropenia. The evolution of oncological care necessitates a shift from purely clinical observation to the precision afforded by biochemical signaling and mechatronic modeling.